CDC Says Novavax COVID-19 Vaccine US Trial Participants Qualify As Fully Vaccinated Two Weeks After Dosing

Reuters (8/30, O'Donnell) reports, “Participants in Novavax Inc’s...late-stage COVID-19 vaccine trial can be considered fully vaccinated two weeks after completing their two-dose vaccine regimen, the U.S. Centers for Disease Control and Prevention said on...